July 11, 2019
Daiichi Sankyo’s peripheral neuropathic pain treatment Tarlige (mirogabalin) was the most heavily pitched drug for GPs in the month of March, ahead of its launch in mid-April, market research firm Anterio’s “Impact Track” survey showed. The Impact Track detailing track...read more